's Information

Name Bon-Kwon Koo
Country Korea (South)
Job Interventional Cardiologist

Other summitMD.com content(s) by This

Cases

  1. Follow-up Result of Very Long Cypher implantation in a Diabetic Patient
  2. Repeat Brachytherapy for a Total In-Stent Restenosis after Intracoronary Brachytherapy
  3. Repeat Brachytherapy for Late Restenosis after Intracoronary Brachytherapy
  4. Acute myocardial infarction without angiographic luminal narrowing
  5. Massive Arterial Graft Dissection After Bypass Surgery Treated With Multiple Drug-Eluting Stents Implantation

Slide Presentations

  1. Fractional Flow Reserve Guided Jailed Side Branch Intervention in Bifurcation Lesions
  2. Clinical Application of FFR in PCI of Bifurcation Lesion
  3. Technical Approach in True Bifurcation Lesions; What We Have Learned from FFR
  4. Physiologic Insight of a Bifurcation Lesion
  5. Pitfalls with FFR Measurements
  6. Diffuse, Serial and Multiple Stenosis
  7. FFR in Bifurcation Lesion
  8. FFR Evalution of Bifurcating Lesion
  9. Case Based Learning
  10. FFR: Basics, Artifacts and Pitfalls
  11. How is FFR Helpful to Treat the Bifurcating Lesions?
  12. FFR-Guided Provisional Stenting: Ischemia or Stenosis
  13. Innovation in Medicine: The Korean Approach
  14. Usefulness of IVUS and FFR in Non-LM Bifurcation PCI
  15. Invited Case: Why Angina After Coronary Bypass Surgery and Stent Implantation?
  16. How PCI? Function-Guided Approach
  17. DISCOVER-FLOW
  18. Predictors of Restenosis and Stent Thrombosis in Bifurcation PCI
  19. FFR-guided Optimization of Bifurcation PCI
  20. Which Is the Best Modality for the Ischemia Guided Functional Angioplasty?: FFR, Thallium SPECT, FFR CT and Others
  21. Why FFR and Why Not FFR in Bifurcation Lesions
  22. Morphologic vs. Functional Assessment for Bifurcation Lesion
  23. Function-guided Bifurcation PCI
  24. FFR at CathLab Today: Moving Closer, But Gaps Remain.
  25. Pharmacologic Agents for Maximal Hyperemia
  26. Non-LM PCI
  27. Multivessel & Bifurcation
  28. How to Utilize FFR and IVUS in Non-LM Bifurcation PCI?
  29. From CTA to CT-FFR
  30. [Debate: Functional Evaluation Is Necessary] Yes, We Need a Function-guidance.
  31. Step-by-Step Approach in Non-LM Bifurcation PCI Using FFR and IVUS
  32. FFR Digest: Evolving from PCI to CABG
  33. Non-Left Main PCI
  34. FFR CT in Progression
  35. Hyperemia
  36. FFR in Bifurcation Lesions: We Should Be More Physiologic Than FFR !
  37. How to Practically Use FFR for Left Main Disease?
  38. FFR vs. Acute Coronary Syndrome: Is There Any Link?
  39. Advanced Application of a Pressure Wire: Dobutamine Stress-FFR, Wedge Pressure
  40. FFR in Bifurcation Lesions: We Should Be More Physiologic Than FFR!
  41. Sketch for FFR Basics, Artifacts, Pitfalls, and Grey Zones
  42. FFR Assessment for Complex Lesion (LM, Bifurcation, Tandem, Etc.)
  43. Novel Non-Invasive Indices to Define Hemodynamic Forces Acting on Coronary Plaque
  44. FFRct: Present and Future
  45. Mechanistic Link Between Hemodynamics and ACS
  46. [Integrated Use of FFR and IVUS: Case Based Learning] Non-Left Main
  47. FFR-Guided Bifurcation Treatment: Treat-or-Not Treat and Bifurcation Techniques
  48. Case 2: Bifurcation, Tandem and Diffuse Disease
  49. Bifurcation PCI: Is It a Matter of Technique or Concept?
  50. Hemodynamic Force and Coronary Plaque: Theoretical Evaluation of Mechanistic Effect
  51. Bifurcation
  52. Vulnerability Assessment Using Physiologic Indices
  53. Real World Use of BES in Korea: From the Host Biolimus Registry
  54. FFRct: Present and Future
  55. Physiology Assesment; FFR, CFR, IFR, IMR
  56. Bifurcation PCI; Why Imaging and Functional Guidance?
  57. How May FFR Help in LM PCI?
  58. EMERALD Study: Exploring the MEchanism of the Plaque Rupture in Acute Coronary Syndrome Using Coronary CT Angiography and ComputationaL Fluid Dynamics
  59. Why Should Be FFR Believer in Non-LM and LM Bifurcation PCI
  60. Future Clinical Role of IMR or Microcirculation Study
  61. What Really Matter in Bifurcation PCI: Technique or Concept
  62. Physiology Guided Complex PCI
  63. How to Make Optimal Resting and Hyperemic Status for Coronary Physiologic Assessment
  64. iFR as the Gold Standard Index!
  65. Role of FFR in ACS (uAP, NSTEMI, and STEMI): Still Doubtful?
  66. Bifurcation PCI with Physiologic Index: FFR, Contrast FFR, Pd/Pa, and iFR - When, How, and What?
  67. Similarities and Dissimilarities of FFR, iFR and Resting Pd/Pa
  68. Physiologic Assessment for Bifurcation Lesion
  69. Coronary Physiology Perspective
  70. Non-Invasive Hemodynamic Assessment for ACS Risk
  71. How to Make Optimal Hyperemia: From Adenosine to Contrast
  72. FLAVOUR: Physiology or Imaging for Revascularization Strategy
  73. Smart PCI with Advanced Co-Registration System
CardioVascular Research Foundation (CVRF)
2nd Floor, Asan Institute for Education & Research, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Korea
Tel_82.2.3010.4792 | Fax_82.2.475.6898
ܹ
ǥ̻ ڽ | ı øȷ43 88, ƻ꺴 ƻ걳 2 | ڵϹȣ 215-82-06387
å_ | ȭȣ_02.3010.4792 | ѽȣ_02.475.6898
Copyright © CVRF, Seoul, Korea. All rights reserved.